Still, researchers point out that these trials involved people with established cognitive symptoms, and its possible GLP1 drugs might be more effective if given earlier, before the neurological damage is advanced
There is still limited information on long-term use, repeated cycles, possible drug interactions, and the effects of BPC 157 in people with complex health conditions
Reduced Fat in the Liver: It helps clear excess fat from the liver, a major contributor to insulin resistance
Advertisement Large retrospective analysis may prompt prospective studies How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more Robust signal from observational study raises prospect of a long-sought medical therapy Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs Surgical intervention linked to increased lifespan and reduced complications